In vitro analysis of breast tumour detection using rotational infrared thermal imaging and machine learning techniques
Source abstract
Abstract
Breast cancer is the most common cancer affecting women worldwide, and various methods, such as biopsy, mammography, 3D tomosynthesis, MRI, ultrasonography, and infrared thermal imaging (ITI), are utilized for its early detection. ITI is a technique that detects variations in thermal patterns on the breast surface, which are caused by the higher metabolic activity and vascularisation of cancerous cells. I As a radiation-free, non-invasive, and cost-effective screening method, ITI has been studied using in-silico, in-vivo, and in-vitro approaches to enhance its diagnostic performance and develop reliable imaging algorithms. Conventional ITI in in-vivo studies is limited by fixed imaging positions, making it difficult to detect deep or hidden tumours. To address these limitations, this study introduces a rotational ITI method integrated with machine learning algorithms in an in-vitro environment. The proposed method generates datasets with varying tumour depths for comprehensive algorithmic analysis. It captures thermal images from four distinct positions (0°, 90°, 180°, and 270°), enabling a more thorough evaluation of the phantom breast surface. Using the combined dataset, which incorporates information from all four positions, the Convolutional Autoencoder and Support Vector Machines methods achieved an accuracy of 98.28%, sensitivity of 97.75%, specificity of 98.82%, and an F1 score of 98.29%.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Infrared Thermography in Medicine · Optical Imaging and Spectroscopy Techniques · Thermography and Photoacoustic Techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Ege University
Manisa Celal Bayar University
Funding
Health Institute of Türkiye
References (100+)
Show source-provided references
1. World Health Organization. World health statistics 2023: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization; 2023.
2. 10.6061/CLINICS/2017(04)0910.6061/CLINICS/2017(04)09 ↗
3. 10.1245/s10434-023-13905-610.1245/s10434-023-13905-6 ↗
4. 10.1016/j.molonc.2008.04.00110.1016/j.molonc.2008.04.001 ↗
5. 10.1016/j.compbiomed.2021.10424810.1016/j.compbiomed.2021.104248 ↗
6. 10.1186/s12859-019-2823-410.1186/s12859-019-2823-4 ↗
7. 10.3390/info1407041010.3390/info14070410 ↗
8. 10.2214/AJR.19.2117710.2214/AJR.19.21177 ↗
9. 10.3390/jcm1215488210.3390/jcm12154882 ↗
10. 10.29271/jcpsp.2020.09.94610.29271/jcpsp.2020.09.946 ↗
11. 10.3390/diagnostics1304059710.3390/diagnostics13040597 ↗
12. 10.1001/jama.2014.609510.1001/jama.2014.6095 ↗
13. 10.1148/RADIOL.201918076010.1148/RADIOL.2019180760 ↗
14. 10.1148/RYAI.23013710.1148/RYAI.230137 ↗
15. 10.1148/ryai.23031810.1148/ryai.230318 ↗
16. 10.1148/RADIOL.201918294710.1148/RADIOL.2019182947 ↗
17. McLaughlin SA. Current controversies surrounding mri screening for breast cancer. Am J Hematol/Oncol. 2015;11:26–30.
18. 10.1148/RADIOL.23057610.1148/RADIOL.230576 ↗
19. 10.1016/j.ultrasmedbio.2024.01.01210.1016/j.ultrasmedbio.2024.01.012 ↗
20. 10.3390/diagnostics1317281110.3390/diagnostics13172811 ↗
21. 10.1001/jamaoncol.2023.375910.1001/jamaoncol.2023.3759 ↗
22. 10.3390/a1611051710.3390/a16110517 ↗
23. 10.18280/ts.40064110.18280/ts.400641 ↗
24. 10.1109/DeSE60595.2023.1046964510.1109/DeSE60595.2023.10469645 ↗
25. 10.1364/boe.41705610.1364/boe.417056 ↗
26. 10.1002/advs.20200339610.1002/advs.202003396 ↗
27. 10.1016/j.clbc.2024.02.01710.1016/j.clbc.2024.02.017 ↗
28. 10.5306/wjco.v2.i1.6410.5306/wjco.v2.i1.64 ↗
29. 10.1364/OE.44887410.1364/OE.448874 ↗
30. 10.1186/s43055-020-00175-510.1186/s43055-020-00175-5 ↗
31. 10.2147/BCTT.S5170210.2147/BCTT.S51702 ↗
32. 10.1016/j.sciaf.2023.e0198710.1016/j.sciaf.2023.e01987 ↗
33. 10.1109/ACCESS.2023.328042210.1109/ACCESS.2023.3280422 ↗
34. 10.59785/tjhest.v1i2.2510.59785/tjhest.v1i2.25 ↗
35. 10.3390/sym1503058210.3390/sym15030582 ↗
36. 10.1016/j.eswa.2021.11565110.1016/j.eswa.2021.115651 ↗
37. 10.21015/vtse.v11i4.168410.21015/vtse.v11i4.1684 ↗
38. U.S. Food & Drug Administration. Breast cancer screening: thermogram No substitute for mammogram. 2023. [cited 2024 Jul 29]. Available from: https://www.fda.gov/consumers/consumer-updates/breast-cancer-screening-thermogram-no-substitute-mammogram
39. 10.5152/jtgga.2010.2410.5152/jtgga.2010.24 ↗
40. 10.1142/S021951941330001910.1142/S0219519413300019 ↗
41. 10.1243/095441101153350810.1243/0954411011533508 ↗
42. 10.1109/51.84437810.1109/51.844378 ↗
43. 10.1016/j.ijthermalsci.2013.03.00110.1016/j.ijthermalsci.2013.03.001 ↗
44. Gautherie M. Atlas of breast thermography with specific guidelines for examination and interpretation. Milan, Italy: PAPUSA; 1989.
45. 10.1016/j.tsep.2021.10114210.1016/j.tsep.2021.101142 ↗
46. 10.1177/1460458223115377910.1177/14604582231153779 ↗
47. 10.1152/jappl.1948.1.2.9310.1152/jappl.1948.1.2.93 ↗
48. 10.1115/1.313850210.1115/1.3138502 ↗
49. 10.1115/1.313853310.1115/1.3138533 ↗
50. 10.1109/TBME.1974.32434210.1109/TBME.1974.324342 ↗
51. 10.1016/0022-5193(62)90025-510.1016/0022-5193(62)90025-5 ↗
52. 10.1016/S0006-3495(68)86527-010.1016/S0006-3495(68)86527-0 ↗
53. 10.1152/jappl.1971.30.5.77910.1152/jappl.1971.30.5.779 ↗
54. 10.1109/ISANP.2017.822886810.1109/ISANP.2017.8228868 ↗
55. 10.3390/app1315875210.3390/app13158752 ↗
56. 10.1016/j.cmpb.2023.10756210.1016/j.cmpb.2023.107562 ↗
57. 10.1115/IMECE2012-8824410.1115/IMECE2012-88244 ↗
58. 10.1007/s11042-020-09600-310.1007/s11042-020-09600-3 ↗
59. 10.1007/s11042-021-11477-910.1007/s11042-021-11477-9 ↗
60. 10.1016/j.compbiomed.2021.10502710.1016/j.compbiomed.2021.105027 ↗
61. 10.1155/2022/429522110.1155/2022/4295221 ↗
62. 10.1016/j.eswa.2022.11877410.1016/j.eswa.2022.118774 ↗
63. 10.1016/j.eswa.2023.11964310.1016/j.eswa.2023.119643 ↗
64. 10.1007/s00521-024-09968-510.1007/s00521-024-09968-5 ↗
65. 10.1002/jemt.2455010.1002/jemt.24550 ↗
66. 10.1016/j.compbiomed.2021.10520510.1016/j.compbiomed.2021.105205 ↗
67. 10.1080/17686733.2021.202501810.1080/17686733.2021.2025018 ↗
68. 10.1016/j.infrared.2014.08.01910.1016/j.infrared.2014.08.019 ↗
69. 10.1007/978-981-10-3147-2_910.1007/978-981-10-3147-2_9 ↗
70. 10.21595/vp.2019.2097810.21595/vp.2019.20978 ↗
71. 10.1115/1.240118110.1115/1.2401181 ↗
72. 10.4103/0971-5916.9101210.4103/0971-5916.91012 ↗
73. 10.1515/cdbme-2019-010010.1515/cdbme-2019-0100 ↗
74. 10.1016/j.infrared.2018.10.02710.1016/j.infrared.2018.10.027 ↗
75. 10.1088/1757-899X/408/1/01203110.1088/1757-899X/408/1/012031 ↗
76. 10.18466/cbayarfbe.117624410.18466/cbayarfbe.1176244 ↗
77. 10.1016/j.sigpro.2012.06.00210.1016/j.sigpro.2012.06.002 ↗
78. González FJ. Thermal simulation of breast tumors. Revista Mex de Física. 2007;53:323–326.
79. 10.1016/j.jart.2017.01.00810.1016/j.jart.2017.01.008 ↗
80. 10.3390/s2210389410.3390/s22103894 ↗
81. Acar Demirci B, Demirci O, Engin M. In silico and in vitro based analyses of thermal behavior of breast tissue. Ankara International Congress On Scientific Research-IX (AICSR); Ankara, Türkiye. Vol. 2. New York, USA: Liberty Academic Publishers; 2023. p. 2616–2625.
82. Technical Bulletins (TB/TDS) for Smooth-On Materials. 2024. [cited 2024 Dec 30]. Available from: https://www.smooth-on.com/documents/?doc=all#dragon-skin-10-medium
83. 10.3390/app1002055110.3390/app10020551 ↗
84. 10.1109/ACCESS.2020.300733610.1109/ACCESS.2020.3007336 ↗
85. 10.3390/s1809279910.3390/s18092799 ↗
86. 10.1007/s13246-018-0681-410.1007/s13246-018-0681-4 ↗
87. 10.1016/j.jpi.2023.10033510.1016/j.jpi.2023.100335 ↗
88. 10.1016/j.promfg.2018.10.02310.1016/j.promfg.2018.10.023 ↗
89. 10.1520/JTE2020004410.1520/JTE20200044 ↗
90. 10.1016/j.aei.2020.10110510.1016/j.aei.2020.101105 ↗
91. 10.1016/j.aiia.2021.05.00210.1016/j.aiia.2021.05.002 ↗
92. 10.3390/s2122773110.3390/s21227731 ↗
93. 10.1561/220000000610.1561/2200000006 ↗
94. 10.1007/BF0145632610.1007/BF01456326 ↗
95. 10.1109/34.19246310.1109/34.192463 ↗
96. 10.30880/jscdm.2020.01.02.00410.30880/jscdm.2020.01.02.004 ↗
97. Simonyan K Zisserman A. Very deep convolutional networks for large-scale image recognition. ArXiv Preprint ArXiv:14091556 2014.
98. 10.1109/CVPR.2016.30810.1109/CVPR.2016.308 ↗
99. 10.1145/130385.13040110.1145/130385.130401 ↗
100. 10.1007/978-1-4757-3264-110.1007/978-1-4757-3264-1 ↗